Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abram Recht

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|May 30, 2020
Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or olderMatthew C Ward, Frank Vicini, Zahraa Al-Hilli, et al.
JCO Oncology Practice|May 10, 2021
Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A MicrosimulationMatthew C Ward, Frank Vicini, Zahraa Al-Hilli, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2022
Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and OlderMatthew C Ward, Abram Recht, Frank Vicini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 10, 2020
Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and CorrelatesMartin C Tom, Sarah M C Sittenfeld, Chirag Shah, et al.
Cancer|April 25, 2003
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year resultsJennifer K Marshall, Kent A Griffith, Bruce G Haffty, et al.
NPJ Breast Cancer|February 23, 2024
Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 studyJean L Wright, Robert Gray, Habib Rahbar, et al.
Chest|May 30, 2013
Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resectionJohn M Varlotto, Laura N Medford-Davis, Abram Recht, et al.
Cancer|April 23, 2013
Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgeryJohn Varlotto, Achilles Fakiris, John Flickinger, et al.
Journal of Geriatric Oncology|March 8, 2021
Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancerChristina A Minami, Rachel A Freedman, Maria Karamourtopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology GroupLorie L Hughes, Molin Wang, David L Page, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|May 30, 2020
Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or olderMatthew C Ward, Frank Vicini, Zahraa Al-Hilli, et al.
JCO Oncology Practice|May 10, 2021
Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A MicrosimulationMatthew C Ward, Frank Vicini, Zahraa Al-Hilli, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2022
Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and OlderMatthew C Ward, Abram Recht, Frank Vicini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 10, 2020
Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and CorrelatesMartin C Tom, Sarah M C Sittenfeld, Chirag Shah, et al.
Cancer|April 25, 2003
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year resultsJennifer K Marshall, Kent A Griffith, Bruce G Haffty, et al.
NPJ Breast Cancer|February 23, 2024
Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 studyJean L Wright, Robert Gray, Habib Rahbar, et al.
Chest|May 30, 2013
Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resectionJohn M Varlotto, Laura N Medford-Davis, Abram Recht, et al.
Cancer|April 23, 2013
Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgeryJohn Varlotto, Achilles Fakiris, John Flickinger, et al.
Journal of Geriatric Oncology|March 8, 2021
Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancerChristina A Minami, Rachel A Freedman, Maria Karamourtopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology GroupLorie L Hughes, Molin Wang, David L Page, et al.
Pageof 13